Knight Therapeutics | GUD - Interest Income



Knight Therapeutics reported CAD2.46M in Interest Income for its fiscal quarter ending in September of 2024.


Interest Income Change Date
Acasti Pharma USD -0.36 172K Dec/2024
Aurora Cannabis CAD 1.97M 633K Jun/2025
Canopy Growth CAD 1.06M 884K Jun/2025
Cronos Group USD 9M 668K Jun/2025
Dianthus Therapeutics USD 3.4M 587K Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Moderna USD 81M 9M Jun/2025
Revvity USD 10.08M 253K Mar/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 948K 38K Jun/2025